Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
hemic and lymphatic diseases | D006425 |
immune system diseases | D007154 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZOLINZA | Merck Sharp & Dohme | N-021991 RX | 2006-10-06 | 1 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
t-cell lymphoma cutaneous | — | D016410 | C84.A |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 17 | 11 | 1 | — | — | 26 |
Lymphoma | D008223 | — | C85.9 | 17 | 10 | 1 | — | — | 22 |
Non-small-cell lung carcinoma | D002289 | — | — | 17 | 11 | 1 | — | — | 22 |
Multiple myeloma | D009101 | — | C90.0 | 13 | 9 | 2 | — | — | 20 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 15 | 7 | 1 | — | — | 19 |
Astrocytoma | D001254 | EFO_0000271 | — | 5 | 2 | 1 | — | — | 6 |
T-cell lymphoma cutaneous | D016410 | — | C84.A | 1 | 4 | 1 | — | 1 | 6 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | 1 | 1 | — | 1 | 4 |
Spinal cord neoplasms | D013120 | EFO_0003828 | C72.0 | 1 | 1 | 1 | — | — | 2 |
Mesothelioma | D008654 | — | C45 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 28 | 4 | — | — | — | 30 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 11 | 13 | — | — | 3 | 22 |
Myelodysplastic syndromes | D009190 | — | D46 | 12 | 10 | — | — | — | 19 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 12 | 8 | — | — | — | 18 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 7 | 8 | — | — | — | 13 |
Glioblastoma | D005909 | EFO_0000515 | — | 9 | 8 | — | — | 1 | 13 |
Follicular lymphoma | D008224 | — | C82 | 8 | 7 | — | — | — | 12 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 9 | 6 | — | — | — | 12 |
Hodgkin disease | D006689 | — | C81 | 9 | 4 | — | — | — | 11 |
Neuroblastoma | D009447 | EFO_0000621 | — | 6 | 3 | — | — | 1 | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Medulloblastoma | D008527 | — | — | 4 | — | — | — | — | 4 |
Oligodendroglioma | D009837 | EFO_0000631 | — | 4 | — | — | — | — | 4 |
Germ cell and embryonal neoplasms | D009373 | — | — | 3 | — | — | — | — | 3 |
Plasma cell neoplasms | D054219 | — | — | 3 | — | — | — | — | 3 |
Esophageal neoplasms | D004938 | — | C15 | 2 | — | — | — | 1 | 3 |
Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 3 | — | — | — | — | 3 |
Primary myelofibrosis | D055728 | — | D47.4 | 2 | — | — | — | — | 2 |
Leukemia myeloid chronic atypical bcr-abl negative | D054438 | — | C92.2 | 2 | — | — | — | — | 2 |
Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 2 | — | — | — | — | 2 |
Teratoma | D013724 | — | D28 | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Depression | D003863 | — | F33.9 | — | — | — | — | 1 | 1 |
Pruritus | D011537 | HP_0000989 | L29 | — | — | — | — | 1 | 1 |
Triple negative breast neoplasms | D064726 | — | — | — | — | — | — | 1 | 1 |
Head and neck neoplasms | D006258 | — | — | — | — | — | — | 1 | 1 |
Pheochromocytoma | D010673 | — | — | — | — | — | — | 1 | 1 |
Paraganglioma | D010235 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Vorinostat |
INN | vorinostat |
Description | Vorinostat is a dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL). It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an apoptosis inducer and an antineoplastic agent. It is a hydroxamic acid and a dicarboxylic acid diamide. It is functionally related to a suberic acid, a hydroxylamine and an aniline. |
Classification | Small molecule |
Drug class | enzyme inhibitors: histone deacetylase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C(CCCCCCC(=O)Nc1ccccc1)NO |
PDB | — |
CAS-ID | 149647-78-9 |
RxCUI | — |
ChEMBL ID | CHEMBL98 |
ChEBI ID | 45716 |
PubChem CID | 5311 |
DrugBank | DB02546 |
UNII ID | 58IFB293JI (ChemIDplus, GSRS) |